Skip to main content
Clinical Trials/NCT03304041
NCT03304041CompletedNot Applicable

Efficacy of Low-FODMAPs Dietary Therapy Versus Traditional Dietary Advice for Diarrhea-predominant Irritable Bowel Syndrome in China - A Prospective Randomized Controlled Trial

Sir Run Run Shaw Hospital1 site in 1 country108 target enrollmentStarted: October 10, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
108
Locations
1
Primary Endpoint
Compare response to diet intervention between different groups.

Study Overview

Brief Summary

The primary aim of our study is to carry out a randomized trial to evaluate the efficacy of low-FODMAPs dietary therapy compared to conventional therapy for IBS patients recruited from tertiary hospitals in China. Secondary aims of this research include an analysis of clinical, physiological and microbiological factors that may predict IBS patient response to this dietary intervention.

Detailed Description

Visit 1:Enrollment & Screening & Run-in period Patients who meet the inclusion criteria will be asked to complete IBS Baseline Assessment Questionnaires according to Rome III.Subjects that meet the criteria will receive verbal and written information about the study and provide written informed consent. After meeting with the dietitian and physician who will provide instructions, they will be asked to complete Combined Nutrient and Lactulose Breath Test.[16] Additionally, a baseline food and symptom diary will be completed in a (minimum) 14 day run-in period after breath test (the first 48hr after the breath test will not be included in this analysis). This diary record prior to the intervention will document baseline symptom severity and capture the habitual diet of IBS patients.

Visit 2: Randomization & Intervention. After the run-in period, patients will come back to the clinic to receive dietary instruction ahead of starting the intervention. At the same visit subjects will provide fresh stool for fermentation analysis (including short chain fatty acids and pressure detection) and blood for cytokines analysis. Subjects will then be randomly assigned to either low FODMAP diet (LFD) group or traditional dietary advice for IBS (TDA) group by computer-generated random number table. Participants will receive food instructions by a dietitian, according to their assignment. Throughout the study, only the dietitian will be aware of the assignment of the intervention given. Both diet therapy will last for 3 weeks, and all the subjects are instructed to complete daily food and symptom diary through a provided booklet. IBS Symptoms Severity Scores (IBS-SSS) is evaluated every week and the dietitian who is not aware of the allocation will make a telephone follow-up to assess patient adherence.

Visit 3: End of treatment & Follow-up. After 3 weeks of intervention, the participants will attend a follow-up appointment and complete the IBS Post-Intervention Assessment Questionnaires. Fresh stools and blood are recollected at this visit to evaluate for possible change in gut microbiota and cytokines after diet intervention.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •18-65 years old.
  • •Meet Rome Rome III criteria for IBS-D.
  • •All these patients should have no abnormality in blood, stool analysis or colonoscopy within the previous 2 years.
  • •No GI alarm symptoms.

Exclusion Criteria

  • •Presence of a severe cardiac, hepatic, nephritic, neurologic disease.
  • •Presence of mental disorders caused by schizophrenia, organic brain disorder or physical disease.
  • •Other comorbid medical conditions (eg.unstable diabetes, unstable thyroid disease).
  • •Previous abdominal surgery except appendectomy or hysterectomy.
  • •Pregnant or lactating women.
  • •Use of probiotics, prebiotics, lactulose, antidiarrheal agents or bowel preparation within the 4 weeks prior to the study.
  • •Participation in any other form of dietary therapy within the 4 weeks prior to the study.
  • •Difficulties in communication.

Arms & Interventions

low-FODMAPs diet

Experimental

The low-FODMAPs diet(LFD) aims to keep oligosaccharides, fructose in excess of glucose, and polyol content at less than 0.5 g each per serving based on previously published data.

low-FODMAPs diet therapy for 3 weeks

Intervention: low-FODMAPs diet (Dietary Supplement)

Traditional dietary advice

Placebo Comparator

Traditional dietary advice (TDA) will focus more on how and when to eat rather than on what foods to ingest . Patients will be instructed to regularly eat, never too much or too little, never to be hungry or too full; to eat in peace and to chew thoroughly; reduce intake of fatty, spicy food, fiber, coffee and alcohol during the intervention period

Traditional dietary advice for 3 weeks

Intervention: Traditional dietary advice (Dietary Supplement)

Outcomes

Primary Outcomes

Compare response to diet intervention between different groups.

Time Frame: three weeks

Primary endpoint will be response to 3-week of diet intervention defined by shows \>50 point reduction in IBS-SSS between baseline and post-intervention scores. The proportion of responders who met primary endpoint in each group will be compared.

Secondary Outcomes

  • Compare changes from baseline in stool frequency between different groups.(Every week, last for three weeks)
  • Improvement in abdominal pain between different groups.(Three weeks)
  • Compare changes from baseline in bloating score between different groups.(Every week, last for three weeks)
  • Compare changes from baseline in stool consistency between different groups.(Every week, last for three weeks)
  • Improvement in stool consistency between different groups.(Three weeks)
  • Compare changes from baseline in abdominal frequency between different groups.(Every week, last for three weeks)
  • Compare changes from baseline in incomplete defecation score between different groups.(Every week, last for three weeks)
  • Compare changes from baseline in abdominal pain score between different groups.(Every week, last for three weeks)
  • Compare changes from baseline in excessive wind score between different groups.(Every week, last for three weeks)
  • Compare changes from baseline in quality of life between different groups.(Three weeks)
  • Compare changes from baseline in urgency score between different groups.(Every week, last for three weeks)
  • Compare changes from baseline in mental health between different groups.(Three weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

DAI Ning

Director of Gastroenterology department

Sir Run Run Shaw Hospital

Study Sites (1)

Loading locations...

Similar Trials